Curium introduces innovative 18F-PSMA PET radiopharmaceutical, Pylclari to treat prostate cancer in Estonia, Finland, Latvia, & Sweden: Paris, France Wednesday, January 29, 2025, ...
EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles: London, UK Wednesday, January 29, 2025, 13:00 Hrs ...
Our Bureau, Mumbai Wednesday, January 29, 2025, 12:15 Hrs [IST] ...
OneSource in Q3FY25 clocked revenues of Rs. 392.6 crore with 18% growth: Our Bureau, Bengaluru Wednesday, January 29, 2025, 12:45 Hrs [IST] OneSource Specialty Pharma formerly kno ...
Neurocrine Biosciences, Inc., is a leading neuroscience-focused, biopharmaceutical company, announced it has amended its agreement with Takeda to develop and commercialize osavampator (NBI-1065845/TAK ...
Indian Pharmaceutical Association- Karnataka State Branch elects Dr M Khalid Khan as president: Our Bureau, Bengaluru Wednesday, January 29, 2025, 11:15 Hrs [IST] Indian Pharmaceu ...
EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...
Nandita Vijayasimha, Bengaluru Wednesday, January 29, 2025, 08:00 Hrs [IST] ...
The Parliamentary Standing Committee on the Union Ministry of Chemicals and Fertilisers has recently asked the Pharmaceuticals & Medical Devices Bureau of India (PMBI), which is the implementing ...
Indian pharma faces decline in R&D productivity, patent expiries, turns to AI to mitigate challenges
Nandita Vijayasimha, Bengaluru Wednesday, January 29, 2025, 08:00 Hrs [IST] ...
SEC asks SII to submit more data for approval of recombinant mAB for dengue treatment in adults: Our Bureau, New Delhi Wednesday, January 29, 2025, 08:00 Hrs [IST] The Subject Exp ...
Gireesh Babu, New Delhi Wednesday, January 29, 2025, 08:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback